Chronic disseminated candidiasis and acute leukemia: Impact on survival and hematopoietic stem cell transplantation agenda

Authors: Grateau, A., Le Maréchal, M., Labussière-Wallet, H., Ducastelle-Leprêtre, S., Nicolini, F.-E., Thomas, X., Morisset, S., Michallet, M., Ader, F.

Source: Médecine et maladies infectieuses. 48(3):202-206

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100057581694.0x000001&indx=1&recIds=ETOCvdc_100057581694.0x000001

A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication

Authors: Ader, F., Bachy, E., Balsat, M., Barraco, F., Benech, N., Bienvenu, A.-L., Billaud, G., Biron, F., Boibieux, A., Chidiac, C., Conrad, A., Ducastelle-Leprêtre, S., Dumitrescu, O., Dupont, D., Escuret, V., Ferry, T., Fossard, G., Frobert, E., Gilis, L., Goutelle, S., Grateau, A., Guillermin, Y., Heiblig, M., Labussière-Wallet, H., Le Maréchal, M., Lebras, L., Lina, B., Lina, G., Miailhes, P., Michallet, A.-S., Michallet, M., Michallet, M.-C., Monneret, G., Morfin-Sherpa, F., Nicolini, F.-E., Perpoint, T., Peyrouse de Montclos, M., Picot, S., Poitevin-Later, F., Quintela, A., Rabodonirina, M., Roux, S., Saison, J., Salles, G., Sarkozy, C., Sénéchal, A., Sobh, M., Thomas, X., Valour, F., Wallet, F., Wallon, M., Wattel, E.

Source: In Clinical Microbiology and Infection July 2016 22(7):636-641

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Authors: Paubelle, E., Ducastelle-Leprêtre, S., Labussière-Wallet, H. l., Nicolini, F. E., Barraco, F., Plesa, A., Salles, G., Wattel, E., Thomas, X.

Source: ANNALS OF HEMATOLOGY. 96(3):363-371

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382387260&indx=1&recIds=ETOCRN382387260

Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation

Authors: Nicolini, F. E., Basak, G. W., Kim, D. W., Olavarria, E., Pinilla-Ibarz, J., Apperley, J. F., Hughes, T., Niederwieser, D., Mauro, M. J., Chuah, C.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 123(15):2875-2880

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN385322803&indx=1&recIds=ETOCRN385322803

S157: BCR::ABL1 DIGITAL PCR IDENTIFIES CHRONIC PHASE CML PATIENTS SUITABLE FOR AN EARLY TKI DISCONTINUATION ATTEMPT: A PATIENT-LEVEL META-ANALYSIS

Authors: Kockerols, C., Dulucq, S., Bernardi, S., Farina, M., Civettini, I., Colafigli, G., Mori, S., Valk, P., Mahon, F.-X., Gambacorti-Passerini, C., Nicolini, F.-E., Breccia, M., Russo, D., Westerweel, P. E.

Source: HemaSphere. 6:58-59

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165722099.0x000001&indx=1&recIds=ETOCvdc_100165722099.0x000001

P705: MULTI-CENTER CHART REVIEW STUDY EXAMINING TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS WITH CHRONIC PHASE (CP) CHRONIC MYELOID LEUKEMIA (CML) TREATED IN THIRD-LINE (3L) OR LATER IN FRANCE

Authors: Nicolini, F. E., Etienne, G., Huguet, F., Gu, M., Bouvier, C., Yocolly, A., Favier, R., Trancart, M., Huynh, L.

Source: HemaSphere. 6:600-601

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165711721.0x000001&indx=1&recIds=ETOCvdc_100165711721.0x000001

P701: COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TREATMENT-FREE REMISSION: DISEASE SEVERITY AND IMPACT ON TFR STATUS

Authors: Saußele, S., Evans, N., Nicolini, F. E., Chelysheva, E., Réa, D., Castagnetti, F., Claudiani, S., Rodrigues, R., Kok, C., Hughes, T.

Source: HemaSphere. 6:596-597

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165711693.0x000001&indx=1&recIds=ETOCvdc_100165711693.0x000001

A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication

Authors: Conrad, A., Le Maréchal, M., Dupont, D., Ducastelle-Leprêtre, S., Balsat, M., Labussière-Wallet, H., Barraco, F., Nicolini, F. E., Thomas, X., Gilis, L.

Source: CLINICAL MICROBIOLOGY AND INFECTION. 22(7):636-641

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN380741244&indx=1&recIds=ETOCRN380741244

Impact of ELN recommendations in the management of first-line treated chronic myeloid leukaemia patients: a French cross-sectional study

Authors: Etienne, G., Huguet, F., Guerci-Bresler, A., Nicolini, F. E., Maloisel, F., Coiteux, V., Dauriac, C., Carpentier, N., Bourdeix, I., Tulliez, M.

Source: BRITISH JOURNAL OF HAEMATOLOGY. 174(1):71-80

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN379014913&indx=1&recIds=ETOCRN379014913

Cidofovir in the Treatment of BK Virus–Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Authors: Philippe, M., Ranchon, F., Gilis, L., Schwiertz, V. r., Vantard, N., Ader, F., Labussiere-Wallet, H. l., Thomas, X., Nicolini, F. E., Wattel, E.

Source: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 22(4):723-730

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN377026676&indx=1&recIds=ETOCRN377026676

The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells

Authors: Mourgues, L, Imbert, V, Nebout, M, Colosetti, P, Neffati, Z, Lagadec, P, Verhoeyen, E, Peng, C, Duprez, E, Legros, L, Rochet, N, Maguer-Satta, V, Nicolini, F-E, Mary, D, Peyron, J-F

Source: Leukemia. 29(10):1993-2002

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194153557.0x000001&indx=1&recIds=ETOCvdc_100194153557.0x000001

Effect of Initial Body Mass Index on Survival Outcome of Patients With Acute Leukemia: A Single-Center Retrospective Study

Authors: Heiblig, M. l., Elhamri, M., Nicolini, F. E., Wattel, E., Michallet, M., Salles, G., Thomas, X.

Source: CLINICAL LYMPHOMA MYELOMA AND LEUKEMIA. 15(SUPP):S7-S13

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN371341016&indx=1&recIds=ETOCRN371341016

Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings

Authors: Michallet, M., Sobh, M., Serrier, C., Morisset, S., Labussiere, H., Ducastelle, S., Barraco, F., Gilis, L., Thomas, X., Nicolini, F. E.

Source: LEUKEMIA AND LYMPHOMA. 56(4):999-1003

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN369714957&indx=1&recIds=ETOCRN369714957

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Authors: Zabriskie, M. S., Eide, C. A., Tantravahi, S. K., Vellore, N. A., Estrada, J., Nicolini, F. E., Khoury, H. J., Larson, R. A., Konopleva, M., Cortes, J. E.

Source: CANCER CELL. 26(3):428-442

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN359790580&indx=1&recIds=ETOCRN359790580

High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation

Authors: Gilis, L., Morisset, S., Billaud, G., Ducastelle-Lepretre, S., Labussi&ere-Wallet, H., Nicolini, F. E., Barraco, F., Detrait, M., Thomas, X., Tedone, N.

Source: BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 49(5):664-670

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN353068714&indx=1&recIds=ETOCRN353068714

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia

Authors: Soverini, S., Branford, S., Nicolini, F. E., Talpaz, M., Deininger, M. W. N., Martinelli, G., Muller, M. C., Radich, J. P., Shah, N. P.

Source: LEUKEMIA RESEARCH -OXFORD-. 38(1):10-20

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN344237292&indx=1&recIds=ETOCRN344237292

Skin allograft for severe chronic GvHD

Authors: Crocchiolo, R., Dubois, V., Nicolini, F. E., Sobh, M., Ducastelle-Lepretre, S., Labussiere, H., Lebras, L., Auxenfans, C., Mojallal, A., Damour, O.

Source: BONE MARROW TRANSPLANTATION -BASINGSTOKE THEN LONDON-. 52(7):1060-1062

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN385304697&indx=1&recIds=ETOCRN385304697

Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients

Authors: Michallet, M., Sobh, M., El-Cheikh, J., Morisset, S., Sirvent, A., Reman, O., Cornillon, J., Tabrizi, R., Milpied, N., Harousseau, J. L., Labussiere, H., Nicolini, F. E.

Source: EXPERIMENTAL HEMATOLOGY -COPENHAGEN THEN EL PASO TEXAS THEN NEW YORK-. 41(12):1008-1015

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN343712556&indx=1&recIds=ETOCRN343712556

Tolerability and efficacy of pegylated interferon--2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia

Authors: Johnson-Ansah, H., Guilhot, J., Rousselot, P., Rea, D., Legros, L., Rigal-Huguet, F., Nicolini, F. E., Mahon, F. X., Preudhomme, C., Guilhot, F.

Source: CANCER -PHILADELPHIA THEN HOBOKEN-. 119(24):4284-4289

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN343635406&indx=1&recIds=ETOCRN343635406

Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib

Authors: Cortes, J. E., Nicolini, F. E., Wetzler, M., Lipton, J. H., Akard, L., Craig, A., Nanda, N., Benichou, A. C., Leonoudakis, J., Khoury, H. J.

Source: CLINICAL LYMPHOMA MYELOMA AND LEUKEMIA. 13(5):584-591

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338828870&indx=1&recIds=ETOCRN338828870